Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consistent chromosome changes in leiomyosarcoma.

S N Sait1, P Dal Cin, A A Sandberg

  • 1Cancer Center, Southwest Biomedical Research Institute, Scottsdale, AZ 85251.

Cancer Genetics and Cytogenetics
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992
Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010
Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010
Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010
Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010
Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010
Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010
See all related articles

Karyotypic analysis of retroperitoneal leiomyosarcoma revealed frequent chromosomal changes. These alterations, including specific gene loci involvement and monosomies, may define a distinct cytogenetic subgroup for this rare cancer.

Area of Science:

  • Oncology
  • Cytogenetics
  • Cancer Research

Background:

  • Leiomyosarcoma is a rare soft tissue sarcoma originating from smooth muscle cells.
  • Accurate diagnosis and classification are crucial for effective treatment strategies.
  • Understanding the genetic landscape of leiomyosarcoma can aid in identifying prognostic markers.

Observation:

  • Karyotypic analysis was performed on a retroperitoneal leiomyosarcoma.
  • Structural and numerical chromosomal abnormalities were identified.
  • A literature review was conducted to compare findings with previously reported cases.

Findings:

  • Specific chromosomal changes were frequently observed, including alterations at 1p13 and 11p13.
  • Monosomy of chromosomes 9, 18, and 22 appeared to be recurrent.

Related Experiment Videos

  • These cytogenetic alterations may be characteristic of leiomyosarcoma.

    • Implications:

    • The identified chromosomal changes could serve as diagnostic markers for leiomyosarcoma.
    • These findings suggest the potential for defining a cytogenetic subgroup within leiomyosarcoma.
    • Further research into these genetic alterations may reveal therapeutic targets.